白云山：子公司药物进入Ⅲ期临床试验

Core Viewpoint - The announcement indicates that Guangzhou Wanglaoji Pharmaceutical Co., Ltd., a subsidiary of Baiyunshan, has officially launched a Phase III clinical trial for the treatment of acute pharyngitis with the product "Keganli Yan Koufuye" [2] Group 1 - The Phase III clinical trial aims to evaluate the efficacy and safety of Keganli Yan Koufuye in treating acute pharyngitis, specifically for the external wind-heat syndrome [2] - The initiation of this clinical trial marks a significant step in the development of the product, potentially leading to its market introduction [2]